“…In Peru, according to simulated clients trained to choose the medroxyprogesterone acetate injectable (DMPA) in the consultation, 84% of providers correctly told clients that menstruation might stop, but only 15% mentioned that temporary infertility might follow discontinuation of the method (León, Monge, Zumarán, García, & Ríos, 2001). Provider deficiencies in implementing service guidelines have been documented for the most frequently used methods-sterilization (Visaria, 1999), intrauterine devices (IUDs; Viberga, Odlind, & Zodzika, 2006), pills (Kim et al, 1998;León, Ríos, & Zumarán, 2005), and injectables (León et al, 2001), as well as emergency contraception (Ngoc, Ellertson, Surasrang, & Loc, 1997) and the Standard Days Method (León, Arévalo, et al, 2007;León, Lundgren, Huapaya, Jha, et al, 2007).…”